Kaijiang Yu to Sepsis
This is a "connection" page, showing publications Kaijiang Yu has written about Sepsis.
Connection Strength
0.739
-
Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an a7 nAChR-dependent pathway. Biomed Pharmacother. 2018 Oct; 106:210-216.
Score: 0.217
-
Long non-coding RNA PVT1 promote LPS-induced septic acute kidney injury by regulating TNFa and JNK/NF-?B pathways in HK-2 cells. Int Immunopharmacol. 2017 Jun; 47:134-140.
Score: 0.199
-
Effects of immunotherapy on mortality in neonates with suspected or proven sepsis: a systematic review and network meta-analysis. BMC Pediatr. 2019 08 05; 19(1):270.
Score: 0.059
-
Uncoupling Protein 2 Drives Myocardial Dysfunction in Murine Models of Septic Shock. Biomed Res Int. 2019; 2019:9786101.
Score: 0.057
-
GTS-21 Protected Against LPS-Induced Sepsis Myocardial Injury in Mice Through a7nAChR. Inflammation. 2018 Jun; 41(3):1073-1083.
Score: 0.054
-
Circulating Exosomes Isolated from Septic Mice Induce Cardiovascular Hyperpermeability Through Promoting Podosome Cluster Formation. Shock. 2018 04; 49(4):429-441.
Score: 0.053
-
Procalcitionin as a diagnostic marker to distinguish upper and lower gastrointestinal perforation. World J Gastroenterol. 2017 Jun 28; 23(24):4422-4427.
Score: 0.051
-
Enhanced Glycolytic Metabolism Contributes to Cardiac Dysfunction in Polymicrobial Sepsis. J Infect Dis. 2017 05 01; 215(9):1396-1406.
Score: 0.050